Efficient production oftrans-4-Hydroxy-l-proline from glucose by metabolic engineering of recombinantEscherichia coli
Authors:
Open Access
- 12 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 66 (5) , 400-408
Abstract
Trans-4-Hydroxy-l-proline (trans-Hyp) is a valuable chiral building block for the synthesis of pharmaceutical intermediates. Bioconversion of l-proline using recombinant strain with proline-4-hydroxylase (P4H) is a preferred biocatalytic process in the economical production of trans-Hyp. In this study, a recombinant E. coli overexpressing hydroxylase (P4H), γ-glutamyl kinase and glutamate-semialdehyde dehydrogenase (ProBA) genes were constructed by knocking out the key genes in the metabolism. These key genes contained putA encoding proline dehydrogenase (PutA) in the l-proline metabolism and other catalytic enzyme genes, sucAB encoding α-ketoglutarate dehydrogenase (SucAB), aceAK encoding isocitratelyase (AceA) and isocitrate dehydrogenase kinase/phosphatase (AceK) in the TCA cycle. This recombinant strain coupled the synthetic pathway of trans-Hyp with TCA cycle of the host strain. It inhibited the consumption of l-proline completely and promoted the accumulation of 2-oxoglutarate (2-OG) as a co-substrate, which realized the highest conversion of glucose to trans-Hyp. A fed-batch strategy was designed, capable of producing 31·0 g l−1 trans-Hyp from glucose. It provided a theoretical basis for commercial conversion of glucose to trans-Hyp. Significance and Impact of the Study:Trans-4-Hydroxy-l-proline (trans-Hyp) is a valuable chiral building block for the synthesis of pharmaceutical intermediates. Unsatisfactory microbial bioconversion resulted in a low yield of trans-Hyp. In this study, we blocked the unwanted blunting pathways of host strain and make the cell growth couple with the trans-Hyp synthesis from glucose. Finally, a recombinant Escherichia coli with short-cut and efficient trans-Hyp biosynthetic pathway was obtained. It provided a theoretical basis for commercial production of trans-Hyp.Keywords
Funding Information
- Natural Science Foundation of Hebei Province (B2016201031)
- Hebei Province Science Foundation for High-level personnel (GCC2014013)
- International S & T Corporation Funding, Ministry of S & T, China (2013DFB30190)
- Hebei University Science Foundation (3333112)
This publication has 21 references indexed in Scilit:
- Proline Availability Regulates Proline-4-Hydroxylase Synthesis and Substrate Uptake in Proline-Hydroxylating Recombinant Escherichia coliApplied and Environmental Microbiology, 2013
- Role of the jelly-roll fold in substrate binding by 2-oxoglutarate oxygenasesCurrent Opinion in Structural Biology, 2012
- A stepwise approach for the reproducible optimization of PAMO expression in Escherichia coli for whole-cell biocatalysisBMC Biotechnology, 2012
- Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenasesTrends in Biochemical Sciences, 2011
- Metabolic capacity estimation of Escherichia coli as a platform for redox biocatalysis: constraint‐based modeling and experimental verificationBiotechnology and Bioengineering, 2008
- Fe(II)/α-Ketoglutarate-Dependent Hydroxylases and Related EnzymesCritical Reviews in Biochemistry and Molecular Biology, 2004
- Construction of a novel hydroxyproline-producing recombinant Escherichia coli by introducing a proline 4-hydroxylase geneJournal of Bioscience and Bioengineering, 2000
- Fermentative Production oftrans-4-Hydroxy-L-proline byClonostachys cylindrosporaBioscience, Biotechnology, and Biochemistry, 1995
- L-671,329, a new antifungal agent. III. Structure determination.The Journal of Antibiotics, 1989
- Herstellung und Verwendung von AminosäurenAngewandte Chemie, 1978